ADAPTIN BIO, INC. 8-K

What Happened Adaptin Bio, Inc. (APTN) announced on April 6, 2026, that its common shares have been approved for quotation on the OTCQB® Venture Market under the ticker symbol APTN. The company filed an 8-K with the SEC reporting this event and attached a press release as Exhibit 99.1.

Key Details

• Date of announcement and filing: April 6, 2026.
• Quotation venue: OTCQB® Venture Market.
• Ticker symbol: APTN.
• Press release documenting the announcement included as Exhibit 99.1 to the 8-K.

Why It Matters Being approved for quotation on the OTCQB allows Adaptin’s common shares to be publicly quoted on a regulated over-the-counter marketplace, which can increase visibility and accessibility for U.S. investors and brokers compared with unquoted shares. For retail investors, this change primarily affects how easily the shares can be searched, quoted, and traded; it does not by itself change the company’s financials or governance, and no other corporate actions were disclosed in the filing.